Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

341. Icd-Categories-Prevalence-Reimbursement Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
     January 01, 2011 - past two decades.7 Specifically, the most notable increases in recent spending are attributable to diabetes … 1,022.3 240-279 Endocrine, nutritional, and metabolic diseases, and immunity disorders diabetes … 14,874 61.9 240-279 Endocrine, nutritional, and metabolic diseases, and immunity disorders diabetes … in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment … of cost and health resource utilization for elderly patients with heart failure and diabetes

342. Future Research Needs for Noncyclic Chronic Pelvic Pain Therapies for Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
     January 01, 2015 - Participants for the MAPP Research Network, United States NCT01098292 National Institute of Diabetes … Enrollment Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic … , United States 5R21DK081773-03 Spaulding Rehabilitation Hospital; National Institute of Diabetes … Study of Chronic Pelvic Pain (MAPP), United States 5U01DK082344-04 National Institute of Diabetes … Pharmacologic treatment · In addition to hormonal therapies, the list of research needs should include

343. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
     September 25, 2024 - Examples of other therapies include structured mindfulness programs and mindfulness-based therapies … , play therapy, dialectical behavior therapy, parent-child interaction therapy) and integrative therapies … , other treatments), and study results (outcomes). … treatments rather than other factors. … Mind-body therapies in children and youth.

344. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - Since there are no FDA approved treatments within the anti-sclerostin monoclonal antibody class, Amgen … vertebral fracture.2,4,6 Therefore, w hile drug holidays may be an option for certain osteoporosis therapies … Lancet Diabetes Endocrinol 2017;5:513-523. … While drug holidays may be an option for certain therapies, DMB should not be discontinued without … Given that there are no other treatments within the anti-sclerostin monoclonal antibody class, this

345. Chronic-urinary-retention-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
     November 19, 2012 - Examples of neurologic causes include spinal cord injury (SCI), stroke, multiple sclerosis (MS), and diabetes … Testing and Treatment Treatment for CUR is dependent on etiology. … , and pharmacologic treatments. … Table 1 lists the various surgical and nonsurgical treatments for CUR. … silodosin); 5-Alpha Reductase Inhibitors (5-ARI): dutasteride, finasteride; AB + 5- ARI combination therapy

346. Nephropathy-Contrast-Induced Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive.pdf
     October 01, 2015 - Background The administration of iodinated contrast media is an essential component of many diagnostic and therapeutic … Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … procedures, and the increasing prevalence of populations vulnerable to CIN (i.e., people having CKD, diabetes … did not observe any meaningful difference by age, baseline renal function, presence or absence of diabetes … Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.

347. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
     October 01, 2019 - from systemic corticosteroids, in particular hyperglycemia, in patients with glucose intolerance and diabetes … on evidence from randomized controlled trials (RCTs) as the gold standard design for evaluating a therapeutic … and individual treatments. … The response to antibiotic therapy as well as corticosteroid therapy in ECOPD likely differs based … therapy versus placebo in ECOPD,48 but identification of responders to systemic corticosteroid treatment

348. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … if this test is able to rule out AD), reduce need for long- term care, and avoid use of ineffective therapies … nasal spray bottles. 33,35,36 Various insulin products already approved for use in patients with diabetes … tool=pubmed 10 therapeutic agents to the central nervous system and treat neurodegenerative

349. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … nasal spray bottles. 32,34,35 Various insulin products already approved for use in patients with diabetes … Furthermore, experts thought that the drug’s well-known safety profile and long history of use (in diabetes … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central

350. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
     August 05, 2010 - Nonpharmacologic interventions (such as physical therapy, weight reduction, and exercise) also help … Question 2 Do the comparative benefits and harms of oral treatments for osteoarthritis vary for certain … disease; history of previous gastrointestinal bleeding (any cause); renal disease; hepatic disease; diabetes … Note that selection of candidates for therapy is outside the scope of this review. … Am J Therapeutics. Previous Report, 2004;11:17-25. 9.

351. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … tracked in the system as of November 30, 2014, and pertain to very different types of diagnostic and treatment … preconception and prenatal care; problems that may occur during pregnancy, including gestational diabetes

352. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - outcome and abstract information on additional potential confounders including obesity, hyperten- sion, diabetes … age (continuous), sex, race (white, black, other), myocardial infarc- tion, congestive heart failure, diabetes … infarction 0.9 0.8–0.9 1.1 0.8–1.5 1.1 0.7–1.5 Congestive heart failure 0.9 0.9–1.0 0.9 0.6–1.3 0.8 0.6–1.3 Diabetes … Paradoxical relations of drug treatment with mortality in older persons. … analysis and external adjustment for unmea- sured confounders in epidemiologic database studies of therapeutics

353. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - These systems contain detailed clinical data about patient care and may be useful for understanding treatment … is that the HIE agreement between provider organizations must include not only use of the data for treatment … the prior year.10,11 Examining subpopulations such as those with multiple conditions and expensive treatments … and administration of intravenous medications including chemotherapy and physical or occupational therapy … Information on specific care plans, such as, physical therapy for a certain number of weeks or a schedule

354. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Patients sometimes also use alternative therapies. … to secondary treatment agents such as corticosteroids and biologic therapies … nonsurgical therapeutic alternative for patients with treatment-refractory disease. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National

355. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
     October 05, 2018 - Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention 1 Evidence-based … drug treatment to maximize therapeutic benefit (e.g., reduced fracture risk) while minimizing harms … estrogen-related treatments), race, sex, comorbid conditions (DM, CKD, CVD), osteoporosis status … intervals CKD chronic kidney disease CTX C-terminal telopeptide CVD cardiovascular disease DM diabetes … Date Section Original Protocol Revised Protocol Rationale 10/5/18 Title Appropriate Use of Drug Therapies

356. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - Lifestyle modification is an important part of the treatment of lipid disorders, diabetes and hypertension … We don't refer to treatments for other chronic diseases as Medication Assisted Treatment. … When we treat diabetes we don't speak of "medication-assisted dietary therapy" -- we say they are on … We would never call medication treatment of hypertension or diabetes "medication- assisted" treatment … counseling and other non-pharmacologic therapies."

357. 15 Crosscutting Potential High Impact June 2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … being investigated to treat chronic diseases requiring ongoing medication, such as tuberculosis, diabetes … Adherence to long-term therapies.

358. Disposition of Comments: CER 228, Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
     April 16, 2020 - chronic pain patients and if they are, they are limited by Medicare to the point they would not be therapeutic … majority of patients have been FORCED to reduce their stable, effective pain medications to a non therapeutic … - Introduction to the American Massage Therapy Association … We note that the type, dosage, and duration of any pain treatment, including opioid therapy, is best … from opioid therapy if safe prescribing practices are not followed.

359. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
     July 01, 2012 - 11-2 of surgically excised tumors from patients with breast cancer); or (3) predict response to treatments … Some examples include heart disease and diabetes. … decisions, or predicting response to treatments (either effectiveness or harms)—or whether it is used … For example, age, sex, smoking, hypertension, diabetes, and cholesterol are all well established risk … HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review.

360. 15 Crosscutting Potential High Impact 2012-12-11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Intelligent Pills (The Raisin System) to Monitor Patient Medication Adherence Effective medical therapy … Adherence to long-term therapies.